Skip to main content

Advocacy

On May 20, the Diabetes Technology Society (DTS) announced the launch of a post-market blood glucose monitoring surveillance program , which will aim to assess and...
An illuminating FDA workshop on bolus calculators and device interoperability identifies key unmet needs in diabetes technology - Adam Brown makes a patient presentation!
What can you do right now to advance diabetes advocacy? A summary from an insightful day at Masterlab.
Back in February, the FDA proposed an update to the nutrition fact labels for food and drinks , which would be the first major update to these labels in over two decades...
Why do we need better and more effective diabetes advocacy?
Kelly and Adam weigh in on the Sanofi Partners in Patient Health Summit.
How a dramatic 23% increase in new diabetes cases impacts people living with diabetes nationwide.
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
by Kelly Close and The diaTribe Foundation Twitter Summary: San Francisco leads the way in urging moderation on the sugar front - our request on understanding that...
The delicate balance of portraying type 1 diabetes in the media.
How much funding is diabetes getting? The answer may shock you.
Will it be the first US city to have warning labels for sugary drinks?
Full-length feature documentary to wrap up in 2017.
Award honors innovations to personalize care.
Closed loop systems, stem cells, smart insulin, and more!
What efforts are currently being done to support CGM access?
Enrollment period now open until January 31 – our guide to navigating the complex world of health insurance.
Why I’m so moved by this $45 billion commitment and its focus on health equality.
Comment by March 26 to ensure that diabetes devices easily communicate with one another, other devices, and software.
An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies

Pages